Inventor
GAGE JENNIFER LYNN
US21 patents
⚠️ This page may combine multiple inventors who share the name “GAGE JENNIFER LYNN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OMEROS CORP
18 patentsUS8343970B2Jan 1, 2013
PDE10 inhibitors and related compositions and methods
OMEROS CORP12 citations92
US7786139B2Aug 31, 2010
PDE10 inhibitors and related compositions and methods
OMEROS CORP16 citations89
US9434707B2Sep 6, 2016
PDE10 inhibitors and related compositions and methods
OMEROS CORP3 citations83
US8685975B2Apr 1, 2014
PDE10 inhibitors and related compositions and methods
OMEROS CORP8 citations83
US8377930B2Feb 19, 2013
PDE10 inhibitors and related compositions and methods
OMEROS CORP11 citations83
US9102643B2Aug 11, 2015
PDE10 inhibitors and related compositions and methods
OMEROS CORP3 citations73
US12030853B2Jul 9, 2024
MASP-2 inhibitors and methods of use
OMEROS CORP4 citations72
US11661418B2May 30, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP4 citations72
US11584714B2Feb 21, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP5 citations71
US11807641B2Nov 7, 2023
MASP-2 inhibitors and methods of use
OMEROS CORP2 citations70
US12486278B2Dec 2, 2025
MASP-2 inhibitors and methods of use
OMEROS CORP0 citations60
US12195427B2Jan 14, 2025
MASP-2 inhibitors and methods of use
OMEROS CORP1 citations60
US10106516B2Oct 23, 2018
PDE10 inhibitors and related compositions and methods
OMEROS CORP0 citations51
US9783521B2Oct 10, 2017
PDE10 inhibitors and related compositions and methods
OMEROS CORP0 citations51
US9650368B2May 16, 2017
Processes and intermediates for the preparation of a PDE10 inhibitor
OMEROS CORP1 citations51
US12110288B2Oct 8, 2024
MASP-2 inhibitors and methods of use
OMEROS CORP0 citations50
US9920045B2Mar 20, 2018
Solid state forms of a PDE10 inhibitor
OMEROS CORP0 citations48
US9879002B2Jan 30, 2018
PDE10 inhibitors and related compositions and methods
OMEROS CORP0 citations36